Evoke Pharma, Inc. Stock Price

NasdaqCM:EVOK Community·US$22.3m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
6 Fair Values set on narratives written by author

Create a narrative

EVOK Share Price Performance

US$10.63

4.98 (88.05%)

US$10.63

4.98 (88.05%)

US$10.63

Fri, 7 Nov 25

Share PriceUS$10.63

EVOK Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Flawless balance sheet with high growth potential.

2 Risks

3 Rewards

View Full Analysis

Evoke Pharma, Inc. Key Details

Last Reported Earnings

Jun 30, 2025

Next Reporting Earnings

n/a

: -2.58
: 96.63%
: -42.07%
: 114.3%

View Full Analysis

About EVOK

Founded: 2007
Employees: 3
CEO: Matthew D'Onofrio
WebsiteView website: www.evokepharma.com

Evoke Pharma, Inc. operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is based in Solana Beach, California.